Revered advocate for people with disabilities, Joni Eareckson Tada has been admitted into the hospital because of complications caused by her fight against breast cancer.
As Christian Headlines previously reported, Tada was diagnosed with breast cancer for the second time in late November 2018.
The 69-year-old author, speaker and artist has long dealt with health complications, having quadriplegia and chronic pain for 51 years.
The post shared that Tada had recently undergone radiation treatment for her cancer. Following the treatment, Tada’s health began to decline causing her to suffer with “significant pain issues, including most recently, difficulty with breathing.”
The post read, “As many of you know, Joni Eareckson Tada recently completed a series of radiation treatments for a recurrence of cancer. In the weeks following, Joni has been challenged with significant pain issues, including most recently, difficulty with breathing.”
It continued, “With these concerns escalating, and Joni's inability to get the sleep needed for recovery, she has been hospitalized for observation and medical oversight.”
The organization also asked Tada’s social media followers to pray for her, citing James 5:16. The post said, “The earnest prayer of a righteous person has great power and produces wonderful results.” -James 5:16
“Knowing the truth of that promise of James 5:16, Joni and Ken would be most grateful for your prayers today. As they express confidence that God is in control, the support of prayerful concern would be deeply appreciated. So... please join us in praying without ceasing!” the post concluded.
Updates on Tada’s condition will be shared on the Joni and Friends blog.
Photo courtesy: Joni and Friends
Kayla Koslosky has been the Editor of ChristianHeadlines.com since 2018. She has B.A. degrees in English and History and previously wrote for and was the managing editor of the Yellow Jacket newspaper. She has written on her blog kaylamariekoslosky.blogspot.com since 2012 and has also contributed to IBelieve.com and Crosswalk.com.